Bringing new drugs to the market is becoming increasingly challenging and complex with multiple perspectives to be considered such as non-clinical, regulatory, clinical, CMC, Market access, statistics and operations among many others. In this webinar, we will discuss key elements needed to design and execute a bench to bedside integrated development strategy to help navigate these challenges in an optimized manner that increases the probability of regulatory approval and commercial success while managing costs and critical timelines. Case studies and client experience will be presented.